Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT DIRECT: Direct MT vs Bridging Thrombolysis in Acute Stroke
NCT03192332Completed
- Sponsor
- Insel Gruppe
- Start
- Nov 2017
- Primary completion
- May 2021
- Countries
- 8
01
Overview
Randomised, open-label trial in ischemic stroke (2 arms), sponsored by Insel Gruppe. Primary endpoint: Modified Rankin Scale Score at 90 days. Started Nov 2017; status: completed.
02
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03192332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192332.